Tech Company Financing Transactions

ZS Pharma Funding Round

ZS Pharma closed a $55 million Series D venture capital round on 3/6/2014. Investors included Novo Ventures, 3x5 Special Opportunity Partners and Adage Capital Management.

Transaction Overview

Company Name
ZS Pharma
Announced On
3/6/2014
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series D
Investors

Novo Ventures (Lead Investor)

3x5 Special Opportunity Partners

Adage Capital Management

Alta Partners (Guy Nehra)

Devon Park Bioventures (Marc Ostro)

RA Capital

Sofinnova Ventures

Proceeds Purpose
Proceeds will be used to advance development of ZS-9, the Company's lead product candidate for the treatment of hyperkalemia, through its New Drug Application (NDA) and Marketing Authorization Application (MAA) submissions in early 2015.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
508 Wrangler Drive 100
Coppell, TX 75019
USA
Phone
(650) 458-4100
Website
www.zspharma.com
Email Address
Not Recorded
Overview
Founded in 2008, ZS Pharma, Inc. is a privately held specialty pharmaceutical company located inFort Worth, Texas.
Profile
ZS Pharma LinkedIn Company Profile
Social Media
ZS Pharma Company Twitter Account
Company News
ZS Pharma News
Facebook
ZS Pharma on Facebook
YouTube
ZS Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Alexander
  Robert Alexander LinkedIn Profile  Robert Alexander Twitter Account  Robert Alexander News  Robert Alexander on Facebook
Chief Financial Officer
Todd Creech
  Todd Creech LinkedIn Profile  Todd Creech Twitter Account  Todd Creech News  Todd Creech on Facebook
Chief Medical Officer
Henrik Rasmussen
  Henrik Rasmussen LinkedIn Profile  Henrik Rasmussen Twitter Account  Henrik Rasmussen News  Henrik Rasmussen on Facebook
Chief Operating Officer
Jeffrey Keyser
  Jeffrey Keyser LinkedIn Profile  Jeffrey Keyser Twitter Account  Jeffrey Keyser News  Jeffrey Keyser on Facebook
President
Al Guillem
  Al Guillem LinkedIn Profile  Al Guillem Twitter Account  Al Guillem News  Al Guillem on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/6/2014: DigitalOcean venture capital transaction
Next: 3/6/2014: Redlen Technologies venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.